GeneMuDx's newly patented invention, DSF-applied assay, permits simultaneous analysis of hundreds genes in hundreds samples. Researchers are invited to join us to form profit-sharing joint ventures.
A joint OHSU and Portland VA cancer research lab specializing in oncogenic mutation detection and development of novel assays for treatment of human cancers
DSF molecular diagnostic lab introduces two novel technologies, DSE and DSF, for sensitive and high throughput mutation screening for early detection of cancer, mrd and drug resistance. Physicians, pathologists and international investors are invited for
DSF molecular diagnostic lab offers our proprietary DSE and DSF assays for sensitive and high hroughput mutation screening assays for cancer genes. These two innovative technologies are soon entering the national phase of PCT patent application. We are se
Genetic Cancer Prediction through Population Screening (GCaPPS) study evaluates feasibility & impact of BRCA gene mutation testing (following genetic counselling) to all Ashkenazi Jews over 18 years.
DSF Diagnostics offers state-of-the-art molecular assays for early detection of cancer, MRD and drug resistance. Our proprietary DSE and DSF assays permit sensitive and high throughput gene mutation detection, thus ideal for large scale studies. These two
DoMSE is a Database of Microorganisms isolated from the Singaporean Environment done within a project for the dissertation -Bioconversion of Lignocellulose to Lactic Acid- at the University of Leipzig in cooperation with A*STAR Singapore.